يعرض 1 - 10 نتائج من 55 نتيجة بحث عن '"Laura Mauri"', وقت الاستعلام: 0.98s تنقيح النتائج
  1. 1
    The OPTIMIZE randomized trial to assess safety and efficacy of the Svelte IDS and RX Sirolimus-eluting coronary stent Systems for the Treatment of atherosclerotic lesions: Trial design and rationale

    المؤلفون: S. Chiu Wong, James P. Zidar, Gheorghe Doros, Steven J. Yakubov, Sunil V. Rao, David Cohen, Laura Mauri, Dean J. Kereiakes, John M. Lasala

    المصدر: American Heart Journal. 216:82-90

    مصطلحات موضوعية: Target lesion, medicine.medical_specialty, Randomization, medicine.medical_treatment, Coronary Artery Disease, Equivalence Trials as Topic, 030204 cardiovascular system & hematology, Prosthesis Design, law.invention, 03 medical and health sciences, Percutaneous Coronary Intervention, 0302 clinical medicine, Randomized controlled trial, law, Angioplasty, Coronary stent, Clinical endpoint, Humans, Multicenter Studies as Topic, Medicine, Single-Blind Method, Everolimus, Prospective Studies, cardiovascular diseases, 030212 general & internal medicine, Myocardial infarction, Randomized Controlled Trials as Topic, Sirolimus, business.industry, Stent, Drug-Eluting Stents, equipment and supplies, medicine.disease, Dilatation, Treatment Outcome, Radiology, Cardiology and Cardiovascular Medicine, business, Immunosuppressive Agents, Platelet Aggregation Inhibitors

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d98b61e51401e1c92efee165857a446aTest
    https://doi.org/10.1016/j.ahj.2019.07.003Test


    أضف إلى المفضلة
  2. 2
    Rationale of a novel study design for the BIOFLOW V study, a prospective, randomized multicenter study to assess the safety and efficacy of the Orsiro sirolimus-eluting coronary stent system using a Bayesian approach

    المؤلفون: Laura Mauri, David E. Kandzari, Jacques J. Koolen, Joseph M. Massaro, Ron Waksman, Donald E. Cutlip, Gheorghe Doros

    المصدر: American Heart Journal. 193:35-45

    مصطلحات موضوعية: Target lesion, medicine.medical_specialty, Randomization, medicine.medical_treatment, 030204 cardiovascular system & hematology, Coronary Angiography, Prosthesis Design, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, Absorbable Implants, Coronary stent, Myocardial Revascularization, Clinical endpoint, Humans, Medicine, Prospective Studies, 030212 general & internal medicine, Myocardial infarction, Sirolimus, business.industry, Coronary Stenosis, Stent, Percutaneous coronary intervention, Bayes Theorem, Drug-Eluting Stents, medicine.disease, Surgery, Treatment Outcome, Cardiology and Cardiovascular Medicine, business, Immunosuppressive Agents, Follow-Up Studies

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbd2dea320fc43e324cb20d98fa073edTest
    https://doi.org/10.1016/j.ahj.2017.08.001Test


    أضف إلى المفضلة
  3. 3
    Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial

    المؤلفون: Johan Bennett, David E. Kandzari, Gheorghe Doros, Ron Waksman, Elie G. Gharib, Joseph M. Massaro, Ariel Roguin, Hector M. Garcia-Garcia, Donald E. Cutlip, Jacques J. Koolen, Laura Mauri

    المصدر: The Lancet. 390:1843-1852

    مصطلحات موضوعية: Target lesion, medicine.medical_specialty, Intention-to-treat analysis, business.industry, medicine.medical_treatment, Percutaneous coronary intervention, Stent, General Medicine, 030204 cardiovascular system & hematology, equipment and supplies, medicine.disease, Surgery, 03 medical and health sciences, surgical procedures, operative, 0302 clinical medicine, Sirolimus, Durable polymer, Clinical endpoint, Medicine, cardiovascular diseases, 030212 general & internal medicine, Myocardial infarction, business, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::2ba70d9f2c63421aa43d97b8c41cda48Test
    https://doi.org/10.1016/s0140-6736Test(17)32249-3


    أضف إلى المفضلة
  4. 4
    Long-term (5-year) clinical evaluation of the Resolute zotarolimus-eluting coronary stent: The RESOLUTE US clinical trial

    المؤلفون: Ajay J. Kirtane, Martin B. Leon, Laura Mauri, Charles O'Shaughnessy, Jeffrey Carr, Minglei Liu, Michael W. Ball, Alan C. Yeung

    المصدر: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac AngiographyInterventionsREFERENCES. 95(6)

    مصطلحات موضوعية: Target lesion, Male, medicine.medical_specialty, Time Factors, medicine.medical_treatment, Population, Coronary Artery Disease, 030204 cardiovascular system & hematology, Risk Assessment, 03 medical and health sciences, 0302 clinical medicine, Percutaneous Coronary Intervention, Recurrence, Risk Factors, Internal medicine, Coronary stent, Medicine, Humans, Radiology, Nuclear Medicine and imaging, Zotarolimus, 030212 general & internal medicine, Myocardial infarction, Prospective Studies, education, Aged, Sirolimus, education.field_of_study, business.industry, Coronary Thrombosis, Dual Anti-Platelet Therapy, Stent, Cardiovascular Agents, Drug-Eluting Stents, General Medicine, Middle Aged, medicine.disease, United States, Clinical trial, Treatment Outcome, Drug-eluting stent, Cardiology, Female, Cardiology and Cardiovascular Medicine, business, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e114563474aa81dcd50c488929616602Test
    https://pubmed.ncbi.nlm.nih.gov/32421244Test


    أضف إلى المفضلة
  5. 5
    Incidence and predictors of unplanned non-target lesion revascularisation up to three years after drug-eluting stent implantation: insights from a pooled analysis of the RESOLUTE Global Clinical Trial Program

    المؤلفون: Gert Richardt, Petr Widimský, Patrick W. Serruys, Ian T. Meredith, Jorge A. Belardi, Franz Joseph Neumann, Shigeru Saito, Alan C. Yeung, Martin B. Leon, Mohamed Abdel-Wahab, Laura Mauri, Sigmund Silber

    المساهمون: Cardiology

    المصدر: EuroIntervention, 12(4), 465-472. EuroPCR

    مصطلحات موضوعية: Target lesion, Adult, Male, medicine.medical_specialty, Time Factors, medicine.medical_treatment, Myocardial Infarction, 030204 cardiovascular system & hematology, Coronary artery disease, Coronary Restenosis, 03 medical and health sciences, 0302 clinical medicine, Percutaneous Coronary Intervention, Restenosis, Risk Factors, Medicine, Humans, Cumulative incidence, 030212 general & internal medicine, Aged, Aged, 80 and over, Sirolimus, business.industry, Incidence, Percutaneous coronary intervention, Stent, Cardiovascular Agents, Drug-Eluting Stents, Middle Aged, medicine.disease, Surgery, Treatment Outcome, Drug-eluting stent, Conventional PCI, Female, Cardiology and Cardiovascular Medicine, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79ee3c03b3492df221e5501da427e89cTest
    https://doi.org/10.4244/eijy15m07_07Test


    أضف إلى المفضلة
  6. 6
    Endeavour zotarolimus-eluting stent reduces stent thrombosis and improves clinical outcomes compared with cypher sirolimus-eluting stent: 4-year results of the PROTECT randomized trial

    المؤلفون: Volkhard Kurowski, Runlin Gao, Laura Mauri, Farqad Alamgir, Keyur Parikh, Erik Lipsic, Eric Boersma, Ph. Gabriel Steg, Frank van Leeuwen, Christoph Bode, John P Greenwood, Tessa Rademaker-Havinga, William Wijns, Peter W. Radke, Edoardo Camenzind

    المساهمون: Cardiology, Psychiatrie & Neuropsychologie, RS: MHeNs - R3 - Neuroscience

    المصدر: European Heart Journal, 35(40), 2812-2820. Oxford University Press

    مصطلحات موضوعية: Male, medicine.medical_specialty, medicine.medical_treatment, PERCUTANEOUS CORONARY INTERVENTION, Late stent thrombosis, law.invention, Coronary Restenosis, POOLED ANALYSIS, Randomized controlled trial, ANTICOAGULATION, law, medicine, Humans, ARTERY-DISEASE, Zotarolimus, Myocardial infarction, BARE-METAL STENTS, Sirolimus, Endothelialization, Surrogate endpoint, business.industry, Coronary Thrombosis, Graft Occlusion, Vascular, DUAL ANTIPLATELET THERAPY, Percutaneous coronary intervention, Stent, Drug-Eluting Stents, NON-INFERIORITY TRIAL, Middle Aged, medicine.disease, Prosthesis Failure, Surgery, Treatment Outcome, MYOCARDIAL-INFARCTION, BIODEGRADABLE POLYMER, Drug-eluting stent, Conventional PCI, Drug Therapy, Combination, Female, IMPLANTATION, Cardiology and Cardiovascular Medicine, business, Immunosuppressive Agents, Platelet Aggregation Inhibitors, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a82e6dc86f40ada2b4cb573d637195a2Test
    https://doi.org/10.1093/eurheartj/ehu318Test


    أضف إلى المفضلة
  7. 7
    Bioresorbable polymer drug-eluting stents – Authors' reply

    المؤلفون: Laura Mauri, Jacques J. Koolen, David E. Kandzari, Gheorghe Doros, Ron Waksman

    المصدر: The Lancet. 391:936-937

    مصطلحات موضوعية: Drug, medicine.medical_specialty, Everolimus, business.industry, media_common.quotation_subject, medicine.medical_treatment, Treatment outcome, Bioresorbable polymers, Percutaneous coronary intervention, General Medicine, 030204 cardiovascular system & hematology, Absorbable Implants, Surgery, 03 medical and health sciences, 0302 clinical medicine, Sirolimus, medicine, Prosthesis design, 030212 general & internal medicine, business, medicine.drug, media_common

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::e8e8e76718d14cfa510bcc7d1246d500Test
    https://doi.org/10.1016/s0140-6736Test(18)30535-x


    أضف إلى المفضلة
  8. 8
    Impact of overlapping newer generation drug-eluting stents on clinical and angiographic outcomes: pooled analysis of five trials from the international Global RESOLUTE Program

    المؤلفون: Martin B. Leon, Stephan Windecker, Frank van Leeuwen, Pascal Vranckx, Petr Widimsky, Patrick W. Serruys, Ian T Meredith, Vasim Farooq, Franz-Josef Neumann, Donald E. Cutlip, Jorge Belardi, Alan C. Yeung, Sigmund Silber, Laura Mauri, Hector M. Garcia-Garcia, Manuela Negoita

    المساهمون: Cardiology

    المصدر: Heart, 99(9), 626-633. BMJ Publishing Group

    مصطلحات موضوعية: Male, medicine.medical_specialty, medicine.medical_treatment, Myocardial Infarction, Kaplan-Meier Estimate, Balloon, Coronary Angiography, Prosthesis Design, law.invention, Coronary Restenosis, Randomized controlled trial, law, Risk Factors, Angioplasty, Internal medicine, medicine, Humans, Myocardial infarction, Angioplasty, Balloon, Coronary, Aged, Interventional cardiology, business.industry, Coronary Stenosis, Stent, Cardiovascular Agents, Drug-Eluting Stents, Middle Aged, medicine.disease, Treatment Outcome, Sirolimus, Propensity score matching, Cardiology, Female, Radiology, Cardiology and Cardiovascular Medicine, business, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f79df241d1eb037a070a0b79f162ef7Test
    https://hdl.handle.net/1765/39926Test


    أضف إلى المفضلة
  9. 9
    5-Year Safety and Efficacy of Resolute Zotarolimus-Eluting Stent: The RESOLUTE Global Clinical Trial Program

    المؤلفون: Robert W, Yeh, Sigmund, Silber, Lianglong, Chen, Shaoliang, Chen, Shirish, Hiremath, Franz-Josef, Neumann, Shubin, Qiao, Shigeru, Saito, Bo, Xu, Yuejin, Yang, Laura, Mauri

    المصدر: JACC. Cardiovascular interventions. 10(3)

    مصطلحات موضوعية: Male, Asia, Time Factors, Myocardial Infarction, Coronary Artery Disease, Kaplan-Meier Estimate, Prosthesis Design, Percutaneous Coronary Intervention, Risk Factors, Humans, Aged, Sirolimus, Clinical Trials as Topic, Evidence-Based Medicine, Coronary Thrombosis, Incidence, Australia, Cardiovascular Agents, Drug-Eluting Stents, Middle Aged, South America, Europe, Treatment Outcome, North America, Drug Therapy, Combination, Female, Platelet Aggregation Inhibitors

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid________::e634a25a82d63e86213d8f30be74c6d7Test
    https://pubmed.ncbi.nlm.nih.gov/28109877Test


    أضف إلى المفضلة
  10. 10
    Five-year follow-up of the Sirolimus-Eluting Stents vs Vascular Brachytherapy for Bare Metal In-Stent Restenosis (SISR) trial

    المؤلفون: Hong Wang, J.J. Popma, Oluseun Alli, Michael H. Sketch, Paul S. Teirstein, Sidney A. Cohen, Laura Mauri, Patricia A. Schleckser, Lowell F. Satler, David R. Holmes

    المصدر: American Heart Journal. 163:438-445

    مصطلحات موضوعية: Male, medicine.medical_specialty, Time Factors, medicine.medical_treatment, Brachytherapy, Urology, Coronary Angiography, Disease-Free Survival, law.invention, Coronary Restenosis, Restenosis, Randomized controlled trial, law, medicine, Humans, Prospective Studies, Prospective cohort study, Sirolimus, business.industry, Stent, Drug-Eluting Stents, Middle Aged, medicine.disease, Coronary Vessels, Surgery, Vascular brachytherapy, Treatment Outcome, Female, In stent restenosis, Cardiology and Cardiovascular Medicine, business, Immunosuppressive Agents, Follow-Up Studies, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1084dce6f699e601cf4da60e1f9de89Test
    https://doi.org/10.1016/j.ahj.2011.11.019Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث